ArticleBMC pediatrics2025
Epidemiology of paediatric snakebites in Northeastern Nigeria: a retrospective single-center study.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Trial
- Predictors of In-Hospital Mortality Among Paediatric Snakebite Patients in Northeastern Nigeria: A Survival Analysis Study.Wellcome open research · 2026Article
- Two lives, one bite: a six-year retrospective study on snakebite envenoming among pregnant women in Northeastern Nigeria.Frontiers in global women's health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundNigeria remains one of the highest burden bearers of snakebite envenoming in sub-Saharan Africa. In Northeastern Nigeria, where agricultural practice, livestock herding and outdoor play—especially during the dark hours—are common, children are frequently exposed to snakes. Due to the unique challenges posed by paediatric snakebite envenoming and the paucity of data on paediatric snakebites, there is need for local research on this subject. The study aims to bridge this knowledge gap by examining the characteristics and outcomes of paediatric snakebites in our setting.
methodsThis was a retrospective study conducted at the Snakebite Treatment and Research Hospital (SBTRH) in Kaltungo, Northeastern Nigeria. Medical records of 723 patients aged 0 to 17 years treated at this facility between 1 January to 31 December 2024 were retrieved. Socio-demographic information and key clinical data were extracted from paper-based records and recorded in a Microsoft Excel document. The association between patient characteristics and likelihood of recovery without complications like amputation, debridement or death, was assessed using univariate and multivariable regression analyses.
resultsThere were 480 male patients (66%) and the median age of patients was 12 (range 1 to 17). Within the study period, snakebites in children were most common in April (n = 102, 14%). Nearly two-thirds of the participants (n = 468, 65%) took four hours or more to present to hospital after being bitten. Indeed, patients who took four hours or more to arrive to hospital were less likely to recover without complications (Unadjusted odds ratio (OR) = 0.24, 95% confidence interval (CI) = 0.12–0.43). A sub-analysis among patients who received antivenom revealed that antivenom dose, time to antivenom administration, and antivenom cost were all significantly associated with likelihood of recovery without complications.
conclusionsThis study found that some patient characteristics may contribute to poor outcomes among paediatric snakebite patients in Northeastern Nigeria. It demonstrated the increased risk of complications among those presenting to hospital more than four hours after being bitten, those without timely antivenom administration, and those who paid for antivenom. We hereby recommend increased awareness and health education on early presentation after snakebites.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.